Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion
2023

Exosome-based Drug Delivery for Diabetes Treatment

publication Evidence: moderate

Author Information

Author(s): Chen Qi, Chen Jie, Liu Yi-Ning, Qi Su-Hua, Huang Lin-Yan

Primary Institution: Xuzhou Medical University

Hypothesis

Exosome-based therapy can improve drug delivery for diabetes and its complications.

Conclusion

Exosomes show great potential as drug carriers for treating diabetes and its complications.

Supporting Evidence

  • Exosomes can protect insulin from degradation and improve its bioavailability.
  • Engineered exosomes can enhance the effectiveness of diabetes medications.
  • Exosomes can improve wound healing in diabetic patients.
  • Exosomes can deliver miRNAs that promote insulin sensitivity.

Takeaway

Exosomes are tiny bubbles that can carry medicine to help treat diabetes and its problems, making them a promising new way to deliver drugs.

Methodology

This review summarizes the benefits of exosomal drug delivery systems, drug loading methods, and their applications in treating diabetes.

Limitations

Challenges include large-scale production, assessing exosome contents, and monitoring treatment safety and effectiveness.

Digital Object Identifier (DOI)

10.20517/evcna.2023.32

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication